Provided by Tiger Trade Technology Pte. Ltd.

Guardant Health Inc.

159.03
-3.7500-2.30%
Post-market: 158.00-1.0300-0.65%19:30 EDT
Volume:1.06M
Turnover:168.62M
Market Cap:21.34B
PE:-45.39
High:164.17
Open:159.52
Low:156.32
Close:162.78
52wk High:176.58
52wk Low:53.40
Shares:134.20M
Float Shares:129.78M
Volume Ratio:0.62
T/O Rate:0.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5037
EPS(LYR):-3.3203
ROE:-4584.47%
ROA:-18.07%
PB:-95.76
PE(LYR):-47.90

Loading ...

Canaccord Genuity Reaffirms Their Buy Rating on Guardant Health (GH)

TIPRANKS
·
May 28

Analysts Are Bullish on Top Healthcare Stocks: Niagen Bioscience (NAGE), Guardant Health (GH)

TIPRANKS
·
May 28

Movement Alert|Guardant Health Rises 5.87% in Pre-Market Trading, Shield Blood Test Included in American Cancer Society Screening Guidelines

Market Focus
·
May 28

Guardant Health Is Maintained at Buy by BTIG

Dow Jones
·
May 28

Guardant Health price target raised to $160 from $155 at BTIG

TIPRANKS
·
May 28

Movement Alert|Guardant Health Rises 5.26% in Regular Trading, Shield Blood Test Included in American Cancer Society Screening Guidelines

Market Focus
·
May 28

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Amid S&P 500, Nasdaq Rally, Middle East Peace Optimism

MT Newswires Live
·
May 27

Sector Update: Health Care Stocks Mixed Premarket Wednesday

MT Newswires Live
·
May 27

Guardant Health Says Shield Blood Test Included in American Cancer Society Guidelines

MT Newswires Live
·
May 27

Guardant Health FDA Win Sparks Interest In Liquid Biopsy Valuation Gap

Simply Wall St.
·
May 27

Guardant Health Chief Commercial Officer Chris Freeman disposes of 24,406 common shares worth $2.9 million

Reuters
·
May 27

Guardant Health Is Maintained at Buy by BTIG

Dow Jones
·
May 26

Guardant Health Inc : Btig Raises Target Price to $155 From $145

THOMSON REUTERS
·
May 26

Assessing Guardant Health (GH) Valuation After A Strong Share Price Run

Simply Wall St.
·
May 24

Guardant Health Chief Legal Officer John G. Saia sells USD 2.11 million common shares

Reuters
·
May 23

Guardant Health Co-CEO AmirAli Talasaz disposes of shares worth $22.18 million

Reuters
·
May 23

Guardant Health director Ian T. Clark disposes of shares worth $735,048.53

Reuters
·
May 23

Guardant Health director Manuel Hidalgo Medina disposes 1,250 shares worth $133,384.38

Reuters
·
May 23

Crinetics Pharmaceuticals to Participate in Jefferies Global Healthcare Conference 2026

GlobeNewswire
·
May 23

Movement Alert|Guardant Health Falls 8.48% in Pre-Market Trading, Pulling Back After FDA Approval-Driven Rally

Market Focus
·
May 22